Today: 16 May 2026
AEVEX Stock Jumps 35% After $320 Million Drone IPO as AVEX Tests Defense-Tech Demand
18 April 2026
2 mins read

AEVEX Stock Jumps 35% After $320 Million Drone IPO as AVEX Tests Defense-Tech Demand

NEW YORK, April 18, 2026, 14:32 EDT

  • AEVEX wrapped up its debut on the NYSE at $26.93, topping its IPO price of $20.
  • Solana Beach’s defense-tech company sold 16 million shares, pulling in $320 million.
  • Investors are circling drone makers linked to U.S. and allied defense contracts as the listing hits the market.

AEVEX Corp. jumped out of the gate, finishing its debut on the New York Stock Exchange roughly 35% above its $20 IPO price. The military-drone maker, which pulled in $320 million from the offering, wrapped up Friday at $26.93, opening the door for public investors to tap into the autonomous defense sector.

No coincidence on the timing. Drones and loitering munitions—the kind that linger near their mark before attacking—plus a host of unmanned systems have become central to military strategy, thanks to their widespread deployment in Ukraine and the Middle East. Governments have responded by ramping up investment in speedier, lower-cost tech for the battlefield.

AEVEX is drawing attention these days as it operates in a crowded spot within the defense sector—not quite a top-tier prime, but far from a niche tech upstart. Its business centers on unmanned aircraft systems (UAS), plus sensor integration, aircraft upgrades, and ISR—industry shorthand for intelligence, surveillance and reconnaissance, or military info gathering and analysis.

Solana Beach, California’s AEVEX priced 16 million Class A shares at $20 apiece, landing inside the $18 to $21 range pitched to investors. Underwriters picked up a 30-day window for up to 2.4 million additional shares. The deal should wrap up on April 20, pending routine closing conditions.

Goldman Sachs, BofA Securities, and Jefferies took the lead on the deal. J.P. Morgan, RBC Capital Markets, and Baird were named as additional bookrunners, while William Blair, Raymond James, and Needham & Co. also appeared on the underwriter lineup.

AEVEX’s recent filing spelled out why investors shrugged off its short track record on the public markets. For the first quarter, the company put revenue in the $200 million to $208 million range—leaping from $53.3 million a year ago—largely thanks to growth in its Tactical Systems segment and momentum from the EUCOM AOR Deep Strike program. It also projected net income of $19 million to $22.5 million, swinging from a $27.3 million loss in the prior year.

AEVEX turned in $432.9 million in revenue for 2025, but closed the year with a net loss of $16.8 million. The company’s funded backlog was roughly $503 million at the end of the period. According to Washington Technology, about 78% of AEVEX’s sales came from U.S. government contracts.

Chief Executive Roger Wells linked the decision to list directly to Pentagon appetite. “Over $50 billion was requested for unmanned autonomous systems, and that’s absolutely in the sweet spot of the systems and capabilities we provide,” Wells told Reuters. Reuters

The Tactical Systems segment at AEVEX pulled in 74.4% of 2025 revenue, its filing shows. That group works on designing and making autonomous defense systems. Over in Global Solutions, the focus is aircraft modification, engineering support, and mission services—covering both manned and unmanned platforms.

The list of public comps remains short, though it’s expanding. AEVEX now sits on the market with other unmanned-systems players like Kratos Defense & Security Solutions and AeroVironment. On the private side, defense-tech outfits such as Anduril Industries and Shield AI are also chasing military contracts.

Still, the risk that makes AEVEX attractive is baked into the story. The company leans hard on government spending—at year-end, 84% of its funded backlog was with the U.S. government, according to its filing. That reliance isn’t without peril; U.S. government programs aren’t set in stone and can face delays, funding cuts, or be scrapped with little warning. All it takes is a budget standoff, a contract dispute, or a canceled program to throw off its revenue trajectory.

AEVEX landed an impressive opening trade, but ringing the bell is only the beginning. The real challenge: turning surging wartime demand into steady, reportable numbers quarter after quarter.

Stock Market Today

  • Hedge Fund Appaloosa Sells Off Major Airline Stocks Amid Rising Fuel Costs
    May 15, 2026, 6:12 PM EDT. Hedge fund Appaloosa Capital has sold its entire stakes in the 'big three' U.S. airlines: Delta Air Lines, American Airlines, and United Airlines. This move comes as the airline industry contends with soaring fuel costs, a key expense that can erode profit margins. Instead, Appaloosa increased holdings in tech and transportation companies Amazon and Uber. The shift signals the hedge fund's reduced confidence in the airline sector's short-term outlook amid cost pressures, favoring firms poised for growth in e-commerce and ride-sharing markets.

Latest articles

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

15 May 2026
Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
AXT delays annual meeting to June after AI-driven stock jump

AXT delays annual meeting to June after AI-driven stock jump

15 May 2026
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized common shares to 120 million from 70 million. Shares closed at $123.78, up 7.65%, after a volatile session. China’s export controls on indium phosphide remain a key risk for AXT’s business.
Hyperscale Data moves higher after $5M tender, all eyes on 10-Q

Hyperscale Data moves higher after $5M tender, all eyes on 10-Q

15 May 2026
Hyperscale Data plans a tender offer to buy up to $5 million of Class A shares at $0.21 each, above the last GPUS trade at $0.146. The company reported a preliminary first-quarter net loss of about $30 million on revenue of $44 million and filed a late notice for its Form 10-Q. The offer is pending board and regulatory approval.
Why VICI Properties Stock Jumped Ahead of Earnings: The Casino REIT’s $1.5 Billion Question
Previous Story

Why VICI Properties Stock Jumped Ahead of Earnings: The Casino REIT’s $1.5 Billion Question

Chevron Stock Falls as Oil Prices Crash — Then Strait of Hormuz Risk Returns
Next Story

Chevron Stock Falls as Oil Prices Crash — Then Strait of Hormuz Risk Returns

Go toTop